YS Annual SG&A
$48.69 M
+$6.22 M+14.66%
31 March 2023
Summary:
As of February 5, 2025, YS annual selling, general & administrative expenses is $48.69 million, with the most recent change of +$6.22 million (+14.66%) on March 31, 2023. During the last 3 years, it has risen by +$17.94 million (+58.34%).YS Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
YS Quarterly SG&A
$15.80 M
-$43.50 K-0.27%
30 September 2023
Summary:
As of February 5, 2025, YS quarterly selling, general & administrative expenses is $15.80 million, with the most recent change of -$43.50 thousand (-0.27%) on September 30, 2023. Over the past year, it has increased by +$640.80 thousand (+4.23%).YS Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
YS TTM SG&A
-$548.71 M
-$45.89 M-9.13%
30 September 2023
Summary:
As of February 5, 2025, YS TTM selling, general & administrative expenses is -$548.71 million, with the most recent change of -$45.89 million (-9.13%) on September 30, 2023. Over the past year, it has dropped by -$578.39 million (-1948.91%).YS TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
YS Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +14.7% | +4.2% | -1948.9% |
| 3 y3 years | +58.3% | +8.8% | -3878.3% |
| 5 y5 years | +58.3% | +8.8% | -3878.3% |
YS Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | at high | -0.3% | -1834.5% |
YS Biopharma Co Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | $15.80 M(-0.3%) | $31.63 M(+2.1%) |
| June 2023 | - | $15.84 M(+4.5%) | $30.99 M(+4.4%) |
| Mar 2023 | $48.69 M | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | $15.15 M(+4.4%) | $29.68 M(+104.4%) |
| June 2022 | - | $14.52 M | $14.52 M |
| Mar 2022 | $42.46 M(+38.1%) | - | - |
| Mar 2021 | $30.75 M | - | - |
FAQ
- What is YS Biopharma Co annual selling, general & administrative expenses?
- What is the all time high annual SG&A for YS Biopharma Co?
- What is YS Biopharma Co annual SG&A year-on-year change?
- What is YS Biopharma Co quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for YS Biopharma Co?
- What is YS Biopharma Co quarterly SG&A year-on-year change?
- What is YS Biopharma Co TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for YS Biopharma Co?
- What is YS Biopharma Co TTM SG&A year-on-year change?
What is YS Biopharma Co annual selling, general & administrative expenses?
The current annual SG&A of YS is $48.69 M
What is the all time high annual SG&A for YS Biopharma Co?
YS Biopharma Co all-time high annual selling, general & administrative expenses is $48.69 M
What is YS Biopharma Co annual SG&A year-on-year change?
Over the past year, YS annual selling, general & administrative expenses has changed by +$6.22 M (+14.66%)
What is YS Biopharma Co quarterly selling, general & administrative expenses?
The current quarterly SG&A of YS is $15.80 M
What is the all time high quarterly SG&A for YS Biopharma Co?
YS Biopharma Co all-time high quarterly selling, general & administrative expenses is $15.84 M
What is YS Biopharma Co quarterly SG&A year-on-year change?
Over the past year, YS quarterly selling, general & administrative expenses has changed by +$640.80 K (+4.23%)
What is YS Biopharma Co TTM selling, general & administrative expenses?
The current TTM SG&A of YS is -$548.71 M
What is the all time high TTM SG&A for YS Biopharma Co?
YS Biopharma Co all-time high TTM selling, general & administrative expenses is $31.63 M
What is YS Biopharma Co TTM SG&A year-on-year change?
Over the past year, YS TTM selling, general & administrative expenses has changed by -$578.39 M (-1948.91%)